MSN: Ketamine nasal spray to become cheaper for Australians with treatment-resistant depression PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t ... Gizmodo: Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases An emerging treatment for clinical depression has reached an important milestone.

Understanding the Context

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ... Wall Street Journal: The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray Ketamine has been in a state of heightened media frenzy ever since the FDA approved the ketamine-derived nasal spray Spravato for treatment-resistant depression in March of 2019. Since then, ketamine ...

Key Insights

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a standalone ...